Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
KinaRx Logo
KinaRx Growth Score
64
CB Rank
153358
Heat Score
54
KinaRx is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia.
Founded
obfuscation
PrivateGrant West Lafayette, Indiana, United States1-10 www.kinarx.com/
Biotechnology
Health Care
Therapeutics
Overview

KinaRx
Total Funding
obfuscation
Growth Score
64
Heat Score
54

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score64
29 pts
in past quarter
Heat Score 54
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About KinaRx

CB Rank
153358
KinaRx is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia.
Founded
obfuscation
PrivateGrant West Lafayette, Indiana, United States1-10 www.kinarx.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Key People

Details

Legal Name KinaRx LLC
Operating Status Active
Company Type For Profit
Founders  Ashkan Emadi, Frederick Holtsberg, Herman Sintim, Joe O’Neill
About the Company
KinaRx LLC is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia, with an emphasis on the treatment of drug resistant tumors.
Contact Email info@KinaRx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

KRX-107
A kinase inhibitor targeting FLT3 mutations in Acute Myeloid Leukemia, including secondary mutations resistant to existing treatments.
Second Generation RET Kinase Inhibitors
Kinase inhibitors designed to target RET-driven cancers and overcome resistance caused by secondary mutations.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant
obfuscation
Grant - KinaRx Logo
Grant - KinaRx
1
obfuscation
National Cancer InstituteGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - KinaRx Logo
Grant - KinaRx
—
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - KinaRx Logo
Grant - KinaRx
—
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - KinaRx Logo
Grant - KinaRx
—
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - KinaRx Logo
Grant - KinaRx
—
National Cancer Institute Logo
National Cancer Institute
Yes
Grant - KinaRx Logo
Grant - KinaRx
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4

Employee Profiles

News
Technology
View Tech Report

IT Spend

$58.8KThis year, KinaRx is projected to spend $58.8K on IT, according to Aberdeen.

Active Website Tech Count

2KinaRx is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is KinaRx's headquarters? KinaRx is located in West Lafayette, Indiana, United States.Who invested in KinaRx? KinaRx is funded by National Cancer Institute.When was the last funding round for KinaRx? KinaRx closed its last funding round on
obfuscation
from a Grant round.Who are KinaRx's competitors? Alternatives and possible competitors to KinaRx may include Relay Therapeutics, Cytokinetics, and  Bristol-Myers Squibb.How much funding has KinaRx raised to date? KinaRx has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|